JPRN-UMIN000013559
Completed
未知
A prospective and multicenter trial of intravenous immunoglobulin therapy for idiopathic pulmonary fibrosis - Intravenous immunoglobulin therapy for IPF
Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine0 sites10 target enrollmentMarch 30, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Coexisting or clinical suspicion of sarcoidosis, hypersensitivity pneumonitis, connective tissue diseases, pneumoconiosis, drug\-induced pneumonitis, infectious disease, pregnancy, coexisting chronic obstructive pulmonary disease (COPD), bronchial asthma, bronchiectasis, neoplasm, severe cardiovascular disease, cerebrovascular disease, chronic kidney disease, or thromboembolism. Patients who were unable to undergo physiologic tests, unable to understand the protocol or provide written informed consent, or who were administered with 20 mg/day or more of predonisolone, immunosuppressive agents, antifibrotic agents, or immunoglobulin during the preceding 3 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Evaluating effect of intravenous midazolam on duration of spinal anesthesiaSpinal Anesthesia.Spinal anesthetics causing adverse effects in therapeutic useE938.7IRCT2014090716415N5Deputy of Research and technology of Isfahan University of Medical Sciences36
Completed
Phase 4
Comparison of Ketamine and Morphine in patients with renal colicRenal Colic.Unspecified renal colicIRCT20180530039917N2Ahvaz University of Medical Sciences136
Completed
Phase 2
Evaluating the effects of intravenous immunoglobulin (IVIG) in COVID-19 patientsIRCT20151227025726N20Shahid Beheshti University of Medical Sciences80
Completed
Phase 3
a clinical trial to find the most appropriate maintenance fluid in children with central nervous system infectioHealth Condition 1: null- to compare the incidence of hyponatremia with maintenance fluids ( isotonic and hypotonic) in children with CNS infectionsCTRI/2012/05/002637Kalawati Saran Chiuldrens Hospital90
Completed
Not Applicable
Randomised placebo-controlled trial of intravenous methylprednisolone in relapsed multiple sclerosis patients without the need for ranitidine coverervous System Diseases: Multiple sclerosis (MS)Nervous System DiseasesMultiple sclerosisISRCTN46231139Department of Health (UK)60